SCHEMBL24745362

SCHEMBL24745362

CC(C)(C)OC(=O)c1[nH]c2c(Br)c(F)ccc2c1CCCOc1cccc2cc(F)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 18/20 0.46
BCL2 P10415 2/20 0.43
BCL2L1 Q07817 1/20 0.43
ALB P02768 1/20 0.41
PRKCD Q05655 3/20 0.40
CAMK2B Q13554 3/20 0.40
CAMK2G Q13555 3/20 0.40
NEK4 P51957 2/20 0.40
CAMK2D Q13557 2/20 0.40
HIPK2 Q9H2X6 2/20 0.40
MAP3K20 Q9NYL2 2/20 0.40
MAP4K5 Q9Y4K4 2/20 0.40
EEF2K O00418 1/20 0.40
MARK3 P27448 1/20 0.40
AXL P30530 1/20 0.40
BCL6 P41182 1/20 0.40
PRKAA1 Q13131 1/20 0.40
MARK2 Q7KZI7 1/20 0.40
PIM3 Q86V86 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30000122 1.00 MCL1 (0.46) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL30938996 0.92 MCL1 (0.45) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL22436687 0.90 MCL1 (0.47) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL29999937 0.90 MCL1 (0.47) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL24745269 0.87 MCL1 (0.58) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL30000896 0.83 MCL1 (0.56) MCL1BCL2BCL2L1PRKCDCAMK2B
SCHEMBL24745163 0.83 MCL1 (0.56) MCL1BCL2BCL2L1PRKCDCAMK2B
SCHEMBL22436730 0.82 MCL1 (0.55) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL30000817 0.82 MCL1 (0.55) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL22436674 0.81 MCL1 (0.46) MCL1BCL2BCL2L1ALBPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957218-A Targeted protein degradation using bifunctional compounds that bind to ubiquitin ligases and target MCL-1 proteins 凯普托尔治疗学股份有限公司 2024-04-30 CN disclosed
WO-2022255888-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed